High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 9, 2005, Pages 591-596

  Kamata, Yuko ^a   Watanabe, Jun ^a   Nishimura, Yukari ^a   Arai, Tsutomu ^a   Kawaguchi, Miwa ^a   Hattori, Manabu ^a   Obokata, Akane ^a   Kuramoto, Hiroyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Cell cycle regulatory proteins; Endometrial carcinoma; p27; skp2

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P27; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; AGED; ARTICLE; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; STAINING; SURVIVAL;

CARCINOMA, ENDOMETRIOID; CELL CYCLE PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 27644445529     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0671-2     Document Type: Article

References (31)

1. KIP in uterin endometrial carcinoma relationship with p53 status. Int J Surg Pathol 6:205-212
2. Akaboshi M, Watanabe J, Fujisawa T, Hattori M, Ohno E, Kuramoto H (2001) Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma (in Japanese). J Jpn Soc Clin Cytol 40:121-127
3. KIP1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 79:439-443
4. Bamberger AM, Riethdorf L, Milde-Langosch K, Bamberger CM, Thuneke I, Erdmann I, Schulte HM, Loning T (1999) Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch 434:423-428
5. Kip1 in prostate cancer. J Urol 170:241-245
6. Cip1 in S phase. J Biol Chem 278:25752-25757
7. Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199
8. Cheng JD, Werness BA, Babb JS, Meropol NJ (1999) Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Clin Cancer Res 5:1057-1062
9. FIGO news (1989) Int J Gynecol Obstet 28:189-193
10. Fujisawa T, Watanabe J, Akaboshi M, Ohono E, Kuramoto H (2001) Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 127:668-674
11. Skp2 -mediated ubiqutinylation of p27. Nat Cell Biol 3:321-324
12. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slongerland J, Krek W (2001) Skp2 is oncogenic and overexpressed in human cancers. PNAS 98:5043-5048
13. Kip1 and of its ubiquitin ligase subunit skp2 in colorectal carcinoma. Cancer 91:1745-1751
14. Kato N, Watanabe J, Jobo T, Nishimura Y, Fujisawa T, Katmata Y, Kuramoto H (2003) Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological parameters. J Cancer Res Clin Oncol 129:222-226
15. Kimura H, Watanabe J, Hata H, Fujisawa T, Kamata Y, Nishimura Y, Jobo T, Kuramoto H (2004) PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. J Cancer Res Clin Oncol 130:161-168
16. Kudo Y, Kitajima S, Miyauchi M, Ogawa I, Takata T (2001) High expression of S-phase Kinase-interacting Protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinoma. Cancer Res 61:7044-7047
17. Kyushima N, Watanabe J, IIata II, Jobo T, Kameya T, Kuramoto H (2002) Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 128:307-312
18. Lahav-Baratz S, Ben-Izhak O, Sabo E, Ben-Eliezer S, Lavie O, Ishai D, Ciechanover A, Dirnfeld M (2004) Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium. Mol Hum Reprod 10:567-572
19. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3:231-234
20. skp2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1:14-19
21. Kip1, polyploidy and centrosome overduplication. EMBO J 19:2069-2081
22. Kip1. Biochem Biophys Res Com 282:853-860
23. Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H (2004) Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but no with prognosis. Anticancer Res 24:2185-2192
24. Schwartz AL, Ciechanover A (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50:57-74
25. Shigemasa K, Gu L, O'Brien TJ, Ohama K (2003) Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 9:1756-1763
26. Signoretti S, Marcotullio LD, Richardson A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M, Pagano M (2002) Oncogenic role of the ubiquitin ligase subunit skp2 in human breast cancer. J Clin Invest 110:633-641
27. Singh SP, Lipman J, Goldman H, Ellis Jr FH, Aizenman L, Cangi MG, Signpretti S, Chiau DS, Pagano M, Loda M (1998) Loss or altered subcelluar localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 58:1730-1735
28. Watanabe J, Sato H, Kanai T, Kamata Y, Jobo T, Hata H, Fujisawa T, Ohno E, Kuramoto H (2002) Paradoxical Expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters. Br J Cancer 87:81-85
29. Yang G, Ayala G, Marzo AD, Tian W, Frolov A, Thompson TC, Harper JW (2002) Elevated skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 8:3419-3426
30. Kip1 protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 3:2269-2274
31. skp2 are essential elements of the cyclin A-Cdk2 S phase kinase. Cell 82:915-925